Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an electrolyte replacement used to treat or prevent hypokalemia. It is essential for nerve conduction, muscle contraction, and maintaining acid-base balance.
## Primary Indications
* Treatment of hypokalemia.
* Prevention of hypokalemia in patients at risk.
## Adult Dosing
* **Treatment of Hypokalemia:**
* Oral: 20-100 mEq per day in divided doses. Severe hypokalemia may require higher doses, up to 200 mEq/day, but this should be guided by frequent serum potassium monitoring.
* Intravenous (IV): Typically administered via infusion. Usual dose is 10-40 mEq per day.
* **Caution:** Rapid IV administration can be fatal. IV infusions should generally not exceed 10 mEq/hour and should not be given undiluted. Maximum concentration for peripheral IV infusion is typically 40 mEq/L; central line may allow higher concentrations (up to 100 mEq/L, but with extreme caution and continuous cardiac monitoring). Dosing and infusion rates depend heavily on severity of hypokalemia, cardiac status, and renal function.
* **Prevention of Hypokalemia:**
* Oral: 20-40 mEq per day in divided doses.
## Pediatric Dosing
* **Treatment of Hypokalemia:**
* Oral: 1-3 mEq/kg/day in divided doses, not to exceed adult doses.
* Intravenous (IV): 0.5-1 mEq/kg per dose, infused slowly. Usual daily maintenance is 20-30 mEq/kg/day. Maximum infusion rate is typically 0.5-1 mEq/kg/hour, not to exceed 10-20 mEq/hour. Higher doses and rates require cardiac monitoring.
* **Prevention of Hypokalemia:**
* Oral: 1 mEq/kg/day.
Dosing for both adults and pediatrics requires careful titration based on serum potassium levels, ECG findings, and clinical status. Local protocols should be consulted for specific IV administration guidelines.
## Dose Adjustments
* **Renal Impairment:** Dose reduction is necessary. Monitor potassium levels closely. Patients with anuria or severe renal failure should not receive potassium supplements.
* **Adrenal Insufficiency:** Increased sensitivity to potassium; monitor closely.
## Contraindications
* Hyperkalemia.
* Conditions where potassium levels may increase (e.g., severe renal impairment, untreated Addison's disease, rapid dehydration, extensive tissue injury).
* Known hypersensitivity to potassium chloride.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal discomfort, flatulence.
* **Serious:** Hyperkalemia (muscle weakness, fatigue, paresthesias, cardiac arrhythmias, cardiac arrest), gastrointestinal ulceration/bleeding/perforation (especially with sustained-release formulations or if taken with insufficient fluid).
## Key Drug Interactions
* **ACE inhibitors, Angiotensin II Receptor Blockers (ARBs), Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), NSAIDs, Heparin, Trimethoprim:** Increase risk of hyperkalemia.
* **Aldosterone antagonists:** May increase potassium levels.
* **Digoxin:** Hyperkalemia can increase digoxin toxicity; hypokalemia can decrease it.
* **Neuromuscular blocking agents:** Potassium can affect the neuromuscular blockade.
* **Sodium-restricted diets, salt substitutes:** Often contain potassium and can lead to hyperkalemia.
## Monitoring
* **Serum Potassium Levels:** Frequent monitoring is crucial, especially during IV administration and dose adjustments.
* **Electrocardiogram (ECG):** To assess for signs of hyperkalemia (peaked T waves, widened QRS, loss of P waves).
* **Renal Function:** Monitor BUN and creatinine.
* **Fluid and Electrolyte Balance:** Monitor other electrolytes and fluid status.
* **Signs and Symptoms of Hypokalemia and Hyperkalemia.**
## Clinical Pearls
* Oral potassium chloride should be taken with meals or a large glass of fluid to minimize gastric irritation.
* Sustained-release formulations are associated with a higher risk of gastrointestinal ulceration and should be used with caution.
* IV potassium administration must be done with extreme caution, using an infusion pump, and with continuous cardiac monitoring for rapid infusions or high doses.
* The goal is to correct hypokalemia without causing hyperkalemia.
***
*This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current prescribing information and institutional protocols before administering this medication.*